334
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Achievement of take-home dose privileges is associated with better-perceived sleep and with cognitive status among methadone maintenance treatment patients

, , , , &
Pages 620-628 | Received 30 Sep 2013, Accepted 18 Feb 2014, Published online: 25 Mar 2014

References

  • Adelson MO, Hayward R, Bodner G, Bleich A, Gelkopf M, Kreek MJ. 2000. Replication of an effective opiate addiction pharmacotherapeutic treatment model: minimal need for modification in a different country. J Maintenance Addict 1:5–13.
  • Amato L, Minozzi S, Davoli M, Vecchi S, Ferri M, Mayet S. 2004. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev 18: CD004147.
  • Aprahamian I, Martinelli JE, Neri AL, Yassuda MS. 2010. The accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer's disease: results from a study of Brazilian elderly with heterogeneous educational backgrounds. Int Psychogeriatr 22:64–71.
  • Barker MJ, Greenwood KM, Jackson M, Crowe SF. 2004. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 18:37–48.
  • Bracken BK, Trksak GH, Penetar DM, Tartarini WL, Maywalt MA, Dorsey CM, et al. 2012. Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation. Drug Alcohol Depend 125:132–139.
  • Buysse DJ. 2013. Insomnia. J Am Med Assoc 309:706–716.
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. 1989. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213.
  • Chen KW, Berger CC, Forde DP, D’Adamo C, Weintraub E, Gandhi D. 2011. Benzodiazepine use and misuse among patients in a methadone program. BMC Psychiatry 11:90.
  • Darke S, McDonald S, Kaye S, Torok M. 2012. Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users. Drug Alcohol Depend 126:309–315.
  • Folstein MF, Folstein SE, McHugh PR. 1975. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198.
  • Hawks RL. 1986. Analytical methodology. NIDA Res Monogr 73:30–42.
  • Johns MW. 1991. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545.
  • Juby A, Tench S, Baker V. 2002. The value of clock drawing in identifying executive cognitive dysfunction in people with a normal Mini-Mental State Examination score. Can Med Assoc J 167:859–864.
  • Leung JCW, Lui VWC, Lam LCW. 2005. Screening for early Alzheimer's disease in elderly Chinese patients using the Chinese Clock Drawing Test. Hong Kong J Psychiatry 15:14–17.
  • Mansukhani MP, Kolla BP, Surani S, Varon J, Ramar K. 2012. Sleep deprivation in resident physicians, work hour limitations, and related outcomes: a systematic review of the literature. Postgrad Med 124:241–249.
  • Mariman A, Vogelaers D, Hanoulle I, Delesie L, Pevernagie D. 2012. Subjective sleep quality and daytime sleepiness in a large sample of patients with chronic fatigue syndrome (CFS). Acta Clin Belg 67:19–24.
  • Marvel CL, Faulkner ML, Strain EC, Mintzer MZ, Desmond JE. 2012. An fMRI investigation of cerebellar function during verbal working memory in methadone maintenance patients. Cerebellum 11:300–310.
  • McLellan AT, Luborsky L, O’Brien CP, Barr HL, Evans F. 1984. The Addiction Severity Index in three different populations. NIDA Res Monogr 55:217–223.
  • Mondal P, Gjevre JA, Taylor-Gjevre RM, Lim HJ. 2013. Relationship between the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale in a sleep laboratory referral population. Nat Sci Sleep 5:15–21.
  • Mura T, Proust-Lima C, Akbaraly T, Amieva H, Tzourio C, Chevassus H, et al. 2013. Chronic use of benzodiazepines and latent cognitive decline in the elderly: results from the Three-city study. Eur. Neuropsychopharmacol 23:212–223.
  • Peles E, Bodner G, Kreek MJ, Rados V, Adelson M. 2007a. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. Addiction 102:289–300.
  • Peles E, Schreiber S, Adelson M. 2009. Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose. Eur Neuropsychopharmacol 19:581–588.
  • Peles E, Schreiber S, Adelson M. 2006a. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend 82:103–110.
  • Peles E, Schreiber S, Adelson M. 2006b. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend 82:211–217.
  • Peles E, Hetzroni T, Bar-Hamburger R, Adelson M, Schreiber S. 2007b. Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial. Addiction 102:1947–1953.
  • Peles E, Schreiber S, Adelson M. 2008. Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT). Eur Neuropsychopharmacol 18:188–193.
  • Peles E, Schreiber S, Gordon J, Adelson M. 2005. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain 113:340–346.
  • Peles E, Schreiber S, Sason A, Adelson M. 2011a. Earning “take-home” privileges and long-term outcome in a methadone maintenance treatment program. J Addict Med 5:92–98.
  • Peles E, Schreiber S, Hamburger RB, Adelson M. 2011b. No change of sleep after 6 and 12 months of methadone maintenance treatment. J Addict Med 5:141–147.
  • Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. 2003. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. J Am Med Assoc 289:2370–2378.
  • Shulman KI. 2000. Clock-drawing: is it the ideal cognitive screening test?Int J Geriatr Psychiatry 15:548–561.
  • Soyka M, Zingg C, Koller G, Hennig-Fast K. 2010. Cognitive function in short- and long-term substitution treatment: are there differences?World J Biol Psychiatry 11:400–408.
  • Stein MD, Herman DS, Bishop S, Lassor JA, Weinstock M, Anthony J, et al. 2004. Sleep disturbance among methadone maintained patients. J Subst Abuse Treat 26:175–180.
  • Taras H, Potts-Datema W. 2005. Sleep and student performance at school. J Sch Health 75:248–254.
  • Wang GY, Wouldes TA, Russell BB. 2013. Methadone maintenance treatment and cognitive function: A systematic review. Curr Drug Abuse Rev 6:220–230.
  • Ward MF, Wender PH, Reimherr FW. 1993. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885–890.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.